Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 1850 of 3499 entries
View as:
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Phase: N/A
Priority: Normal
Start: 11/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/17/21
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 03/30/17
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 04/23/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/16/17
End: 06/03/26
Due: 06/03/27
Phase: N/A
Priority: Normal
Start: 06/22/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/24/20
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 12/02/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/10/24
End: 01/10/28
Due: 01/10/29
Phase: N/A
Priority: Normal
Start: 02/06/24
End: 05/03/26
Due: 05/03/27
Phase: N/A
Priority: Normal
Start: 07/05/11
End: 01/01/16
Due: 01/01/17
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 09/24/15
End: 03/25/25
Due: 03/25/26
Phase: N/A
Priority: Normal
Start: 12/21/15
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 04/12/93
End: 03/03/08
Due: 03/03/09
Phase: N/A
Priority: Normal
Start: 11/28/12
End: 10/08/20
Due: 10/08/21
Phase: N/A
Priority: Normal
Start: 09/28/15
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 04/30/07
Due: 04/30/08
Phase: N/A
Priority: Normal
Start: 06/29/17
End: 12/20/19
Due: 12/20/20
Phase: N/A
Priority: Normal
Start: 10/27/17
End: 09/27/21
Due: 09/27/22
Phase: N/A
Priority: Normal
Start: 07/20/07
End: 11/01/20
Due: 11/01/21
Phase: N/A
Priority: Normal
Start: 02/29/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/97
End: 12/31/02
Due: 12/31/03
Phase: N/A
Priority: Normal
Start: 10/30/13
End: 09/28/20
Due: 09/28/21
Phase: N/A
Priority: Normal
Start: 12/31/02
End: -
Due: -